Product Safety Recalls

Product Recall Tracker

CETIRIZINE HYDROCHLORIDE Recall D-0348-2025

Description: Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc., Distributed by: Amazon. NDC# 72657-129-35

CETIRIZINE HYDROCHLORIDE Recall D-0348-2025 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0348-2025
Event ID96474
BrandCETIRIZINE HCL
Generic NameCETIRIZINE
ManufacturerCETIRIZINE
Original Package?1
Active SubstanceCETIRIZINE HYDROCHLORIDE
Drug RouteORAL
DistributionU.S. Nationwide
QuantityN/A
Recall ReasonCGMP Deviations
Drug ClassificationClass II
Drug Code Info20250416
Product NDC72657-128 72657-129 72657-130
Drug UPC0372657129350 0372657128353
Recall Initiation Date20250313
Report Date20250416
Classification Date20250408
Address750 Corporate DrN/A
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient Identifier64O047KTOA
Drug Application NumberANDA078427
Structured Product Labeling (SPL ID)fd1924df-96c1-4429-944d-bd09a7dd2a6b
Structured Product Labeling (SPL Set ID)04b08c52-5390-4cdb-a9e7-fca81fffdc73
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.